Study finds treatment for critical COVID-19 patients

COVID-19 patients who suffer from ARDS were given a treatment of an anti-inflammatory protein in a phase 2 clinical trial.

SARS-CoV-2, the novel coronavirus that causes COVID-19 (illustrative).

SARS-CoV-2, the novel coronavirus that causes COVID-19 (illustrative).

(photo credit: PIXABAY)

ByJERUSALEM POST STAFF

MARCH 13, 2022 04:37

Updated: MARCH 13, 2022 05:15

RECOMMENDED STORIES

Smoke rises following an Israeli attack in Tehran, Iran, June 18, 2025.

IDF symbolically strikes in Tehran after Trump orders Netanyahu to turn planes around

JUNE 24, 2025

Iranian missile falls in Southern Negev.

Five killed, at least 20 wounded as Iran fires missile salvo at Israel

JUNE 24, 2025

Former Hamas leader Yahya Sinwar looks on at an anti-Israel rally, in Gaza City, in 2022.

Hamas leaders' October 7 letter reveals attack strategy and plea to Hezbollah

JUNE 24, 2025

Iran's Foreign Minister Abbas Araghchi speaks in Baghdad, Iraq October 13, 2024.

Iran's FM claims Tehran stopped attacks after Trump announces ceasefire with Israel

JUNE 23, 2025

Hot Opinion

Israel must not let urgent challenges overshadow the human stories behind them

ByJPOST EDITORIAL

Jpost_Image

Grammy-winning producer Lawrence ‘Boo’ Mitchell gives master class to Israeli music students

Netanyahu, learn from Trump, sometimes you just have to do the right thing

Take the win: Why Israel should take Trump's ceasefire with Iran